The title specifies no DAC, while the description also discusses long-acting albumin-binding CJC-1295. Preserve the no-DAC distinction rather than transferring the DAC trial's duration or findings to this listing.
These are selected studies of individual ingredients or related identities. They did not validate the seller's finished blend. Open the linked profile for the population, design, results, and limitations.
INGREDIENT / RELATED IDENTITY
Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. · 2005
Related conjugate · Animal and cell study · 2005
What did this publication test, and what did it find?
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.
Human pharmacology trials · 2006
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.
A product description or general purity claim does not verify every ingredient or ratio in a purchased lot. Match the lot identifier, analytes, methods, and quantitative results to the specific material; a certificate does not establish a clinical outcome.
Educational product reference. No dosing, mixing, or administration instructions are provided. Medical and full-formulation evidence review remain pending.